|

The Role of Levator Ani Muscle Reconstruction Technology in Urinary Incontinence Recovery

RECRUITINGN/ASponsored by Peking University First Hospital
Actively Recruiting
PhaseN/A
SponsorPeking University First Hospital
Started2024-07-22
Est. completion2025-07-21
Eligibility
Age18 Years – 80 Years
SexMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06543420

Summary

This study is a single center, single blind, prospective randomized controlled trial. Patients undergoing robot assisted laparoscopic radical prostatectomy for prostate cancer were randomly divided into 1:1:1 groups, using lateral reconstruction, posterior reconstruction, or no reconstruction. Patients were followed up regularly after surgery and clinical data were collected, including daily use of urine pads, ICIQ-SF score, 24-hour urine leakage, I-QoL score, etc., to evaluate the improvement effect of lateral reconstruction on urinary control and the difference in effect between lateral reconstruction and posterior reconstruction, thereby improving the quality of life of prostate cancer patients after surgery.

Eligibility

Age: 18 Years – 80 YearsSex: MALEHealthy volunteers accepted
Inclusion Criteria:

* Diagnosed with prostate cancer and preoperative clinical stage of cT2\~T3aN0M0
* Complies with the indications for RARP surgery

Exclusion Criteria:

* History of urinary incontinence or urethral stricture
* Previous prostate related surgical treatment
* Contraindications for RARP surgery
* The patient or their family members refuse to participate

Conditions2

CancerProstate Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.